Home
<
Health
(2310)
- Alternative & Complementary Health Care (84)
- Health Research (34)
- Medical & Hospital Care (202)
- Medical Conditions & Diseases (143)
- Mental Health (70)
- Pharmaceuticals (8)
- Public Health (1335)
- Navigating COVID-19 for creative industries (Victoria)
- Navoban (R) : Tropistron
- Nearly there : return to normality with 80 and 90 vax rates
- Neck and shoulder pain
- Needlestick injury
- Negative emotions : coping tips
- Neonatal services review
- Neoral (R) : Cyclosporin
- Neotigason : Acitretin
- Nervous system
- Netball : preventing injury
- Neulasta (R) : Pegfilgrastim (rbe)
- Neupogen (R) : Filgrastim (rbe)
- Neuralgia explained
- Neurofibromatosis
- Neurolite (R) : Technetium Tc-99m Bicisate dihydrochlorite
- Neuromuscular system
- Neuronal intestinal dysplasia
- Neurontin* : Gabapentin
- New celery supertooth school project
- New directions for Victoria's mental health services : the next five years : the plain English version
- New models and approaches to care
- New pop-up vax sites for 100 postcodes across Victoria
- New restrictions are now in place for extreme risk zones
- Newborn screening
- Nexium (R) : Esomeprazole magnesium trihydrate
- Nexium (R) Hp7 (R) : Esomprazole, amoxycillin trihydrate and clarithyromycin
- Nightmares and children
- Nimbex (R) injection : Cisatrocurium besylate
- Nipple piercing
- Nolvadex (R) : Tamoxifen citrate
- Non-specific urethritis : signs and symptoms
- Noonan syndrome
- Nordette (R) : Levonorgestrel and Ethingoestadiol tablets
- Noriday (R) 28 day tablets : Norethisterone
- Norimin 28 day tablets : Ethinyloestradiol and Norethisterone
- Norimin-1 (R) 28 day tablets : Ethinyloestradiol and Norethisterone
- Norinyl-1 (R) 21 and Norinyl-1 (R) 28 day tablets : Mestranol and Norethisterone
- Noroxin (R) : Norfloxacin
- Norprolac (R) : Quingolide
- Northern metropolitan region funding allocation 2003 - 04
- Norvasc (R) tablets : Amlodipine (am-load-i-peen) besylate
- Nosebleeds
- Notifiers' guide to completion of the Victorian perinatal morbidity statistics form
- Nufloxib : contains active ingredient norfloxacin
- Nupetin : contains the active ingredient Gabapentin
- Nutrition : women's extra needs
- Nutrition standards for menu items in Victorian hospitals and residential aged care facilities.
- NutropinAq (Somatropin (INN) recombinant DNA origin, Escherichia coli.)
- Nuts
- Nyogel (R) : timolol
- OHS Leadership/Achievement : Delta Group
- OHS essentials : agriculture
- OHS essentials : healthcare
- OHS essentials : manufacturing
- OVA system analysis of out of home care workers
- Obesity
- Obesity and hormones
- Obesity in children : causes
- Obesity in children : management
- Obesity surgery
- Obsessive compulsive disorder
- Obsessive compulsive disorder : family and friends
- Occupational therapy
- Octostim (R) : Desmopressin acetate
- Odyssey House Victoria
- Office of Senior Victorians
- Office of the Senior Practitioner : strategy framework
- Olive oil
- Omepral (R) tablets : multiple unit pellet system : Omeprazole magnesium
- On the record (Australian Nursing and Midwifery Federation. Victorian Branch)
- Ondansetron (TM): Ondansetron
- One year on : stories of COVID-19 in Melbourne's suburbs
- Opportunities for women in sport
- Oppositional defiant disorder
- Oral health
- Oral health for older people : a practical guide for aged care services
- Oral health guidelines for Victorians
- Organ donation
- Organic food
- Orienteering : preventing injury
- Orudis (TM)
- Oruvail (R) SR capsules : Ketoprofen
- Orygen Youth Health
- Osgood Schlatter syndrome
- Osteoarthritis
- Osteomyelitis
- Osteopathy
- Osteoporosis
- Osteoporosis and disability
- Osteoporosis and exercise
- Otocomb otic* : Triamcinolone acetonide, neomycin as suphate, gramicidin & nystatin
- Otodex (R) : Framycetin sulfate, gramicidin, dexamethasone
- Ottawa Charter for Health Promotion
- Our midwives : Eleanore
- Our midwives : Hannah
- Our nurses : Elise
- Our nurses : Jennifer
- Our nurses : Peter
- Our pathway to change : eliminating bullying and harassment in healthcare